Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
主要な著者: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Oxford University Press
2018
|
類似資料
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
著者:: Wattanakul, T, 等
出版事項: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
著者:: Thanaporn Wattanakul, 等
出版事項: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
著者:: Chotsiri, P, 等
出版事項: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
著者:: Pukrittayakamee, S, 等
出版事項: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
著者:: Saito, M, 等
出版事項: (2018)